Abeta antibody parenteral formulation

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/18 (2006.01) A61K 9/00 (2006.01) A61K 39/395 (2006.01) A61K 47/00 (2006.01)

Patent

CA 2671968

The present invention relates to a stable pharmaceutical parenteral formulation of an antibody, antibody molecule, a mixture of antibodies and/or a mixture of antibody molecules against the amyloid-beta peptide (Abeta) and a process for the preparation. Furthermore, corresponding uses are described.

La présente invention concerne une formulation parentérale pharmaceutique stable d'un anticorps, d'une molécule d'anticorps, d'un mélange d'anticorps et/ou d'un mélange de molécules d'anticorps dirigés contre le peptide bêta-amyloïde (Abêta) et un procédé de préparation associé. En outre, cette invention concerne également des utilisations correspondantes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Abeta antibody parenteral formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Abeta antibody parenteral formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Abeta antibody parenteral formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1557052

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.